Skip to content
memoinOncology Logo memoinOncology Logo memoinOncology Logo
  • CONGRESS REPORTS
    • Solid Tumors
      • ASCO
      • EANM
      • ESMO
      • ESMO IO
    • Hematology
      • ASH
      • EHA
      • ESH CLL
      • ISHL
      • iwWM
    • Lung Cancer
      • ASCO
      • CSCO
      • ECC
      • ELCC
      • ESMO
      • ESMO Asia
      • WCLC
  • MEDICAL EDUCATION
    • Clinical Trials
    • Preceptorship reports
    • Articles
  • COLLABORATIONS
    • CSCO
    • LACOG
    • SEO
    • SSO
  • SUPPORTER
    • Boehringer Ingelheim in Oncology
    • BeiGene
    • ITM
  • MORE…
    • ABOUT US
    • LINKS
    • CALENDAR
    • VIDEOS

DUBLIN-3: microtubule-binding agent plinabulin in later lines

DUBLIN-3: microtubule-binding agent plinabulin i

Read More

ATALANTE-1: anti-cancer vaccination after IO failure

ATALANTE-1: anti-cancer vaccination after IO fai

Read More

Gradual progress in the management of mesothelioma and thymoma

Gradual progress in the management of mesothelio

Read More

Malignant pleural mesothelioma: immunotherapy-based approaches in all treatment lines

Malignant pleural mesothelioma: immunotherapy-ba

Read More

Small-cell lung cancer: on the road to improved efficacy and tolerability

Small-cell lung cancer: on the road to improved

Read More

Immunotherapy: boosting efficacy and overcoming resistance

Immunotherapy: boosting efficacy and overcoming

Read More

Innovative and established agents across a range of targets

Innovative and established agents across a range

Read More

Expansion of treatments and insights in the early-stage disease setting

Expansion of treatments and insights in the earl

Read More

Preface

Preface – ESMO 2021 Alex A. Adjei, MD,

Read More

Sponsors:
This website is intended only for healthcare professionals outside the US, the UK, and Australia   |   This website is supported by an unrestricted medical education grant from BeiGene, Boehringer Ingelheim and ITM
© Copyright 2012 -  memoinOncology BY SPRINGER-VERLAG GmbH   |   Projekt: infill healthcare communication GmbH.   |   Alle Rechte vorbehalten.   |   Die Nutzung der Inhalte ist ausschließlich für den privaten Gebrauch bestimmt. Die über den persönlichen Gebrauch hinausgehende Vervielfältigung und Verbreitung ist nicht gestattet.
Impressum   |   Datenschutzerklärung   |   AGB   |   Kontakt   |   Cookie Einstellungen

Accessibility by WAH